1. Grover GJ, 1994, Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J Cardiovasc Pharmacol 24 (Suppl. 4):S18-S27.
2. Auchampach JA, Maruyama M, Cavero I, Gross GJ, 1991, The new K+ channel opener aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J Pharmacol Exp Ther 259:961–967.
3. Ohta H, Jinno Y, Harada K, Ogawa N, Fukushima, Nishikore J, 1991, Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart. Eur J Pharmacol 204:171–177.
4. Sargent CA, Smith MA, Dzvvonczyk S, Sleph PG, Grover GJ, 1991, Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents. J Pharmacol Exp Ther 259:97–103.
5. Gross GJ, Auchampach JA, 1992, Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70:223–233.